S. 1041 is a bill that aims to update U.S. patent laws regarding biological products to address patent infringement issues. It allows the sponsor of a biologic drug reference product to sue an applicant for a similar product for infringement on a limited number of patents,...
S. 1041 is a bill that wants to change some rules about biological medicines so that people who make them can protect their ideas but still let others try to make similar medicines in a fair way.
S. 1041, also known as the “Affordable Prescriptions for Patients Act,” seeks to change patent laws to address how patents for biological products are handled when there's an accusation of patent infringement. The bill specifically limits the number of patents a reference...
The Affordable Prescriptions for Patients Act is a new rule that tries to make medicine cheaper by changing how many patents a company can use when they argue about who invented a medicine made from living things. It also sets limits to help keep the fight fair so everyone can get the medicine they need.
Showing 1 to 2 of 2 results